A Note from the CEO, Jennifer Hawks Bland |
|
Good morning NewYorkBIO community,
I am so proud of the work that our member companies are doing to bring coronavirus vaccines and therapeutics to the world. These companies are using sound scientific principles and acting with high ethical and safety standards. Scientific integrity is the key to ensuring the public will take vaccines and therapeutics once they are authorized for use. In this time of unprecedented challenges, our life science community is rising to the occasion and I look forward to the continued collaboration across the globe as we work together to halt the spread of coronavirus.
|
|
NewYorkBIO's Virtual Breakfast Series
Tuesday, October 13th, 9:00am
|
|
|
|
Elizabeth Schwarzbach
CBO, New York Stem Cell Foundation Research Institute
We are looking forward to our next episode of the Virtual Breakfast Series on Tuesday. Our guest is Elizabeth Schwarzbach, the Chief Business Officer of the New York Stem Cell Foundation's Research Institute.
|
|
Elizabeth Schwarzbach
Dr. Elizabeth Schwarzbach is the Chief Business Officer at the New York Stem Cell Foundation (NYSCF) Research Institute, accountable for identifying, executing, and managing collaborations and partnerships with industry, disease foundations, research institutes, and academic organizations.
She has over 20 years of experience in academia and biopharma drug discovery and development. She began her career as a biologist in Merck Research Labs in West Point, Pennsylvania, which ignited her passion for pharmacology and lead her to pursue a degree at the University of Pennsylvania School of Medicine. She completed her PhD dissertation, ‘Determining the Mechanisms Contributing to the Inability to Induce Hippocampal Long Term Potential following Traumatic Brain Injury’ in the laboratory of Dr. Akiva Cohen. As a manager with L.E.K. Consulting’s Life Sciences practice, Elizabeth led numerous strategic engagements with pharmaceutical, biotech, and financial services companies to provide actionable recommendations and key insights to inform growth strategies, investment decisions (including due diligence and licensing and M&A transaction support), or portfolio optimization.
Elizabeth then transitioned to GlaxoSmithKline R&D Strategy team. As a non-profit leader, Elizabeth served as Chief of Staff of Sanford Burnham Prebys Medical Discovery Institute, a private research institute headquartered in La Jolla, California. Most recently, Elizabeth was the Head, Business Development for Axovant Sciences, a company that was developing a compound, Intepirdine, for Alzheimer’s disease. The Phase III clinical trial showed no improvement over control group, which highlighted the challenges in translating compounds for neurodegeneration discovered and tested solely in animal models to impactful products for patients and the importance of human disease-relevant models for effective translational science.
|
|
|
|
Virtual: The New York Stem Cell Foundation Conference
October 20 & 21, 2020
|
|
The NYSCF Conference is the leading scientific meeting on translational stem cell research. It annually convenes over 500 participants from academia, industry government, non-profits, and patient groups. This year’s keynote will be given by Carl H. June, MD, of the University of Pennsylvania. Additional speakers will include world-renowned, multi-disciplinary scientists, who will present their latest findings about the transformative impact of stem cell research on numerous diseases with a high unmet need.
This year’s NYSCF conference will be held virtually — featuring live video poster presentations, numerous opportunities for video and chat interactions with the stem cell community, and breakout rooms to interact with our speakers.
|
|
|
|
Virtual: The NYC Life Science Innovation Showcase Conference
November 12, 2020
|
|
Join New York City’s most talented life science entrepreneurs showcase their work to investors and biopharma business executives. By fostering collaborative relationships between these entrepreneurs and the investment community, they aim to help bridge the gap in translating groundbreaking discoveries into biomedical realities and to catalyze entrepreneurship within New York City’s broad and diverse life science ecosystem.
Click the link below to register and view the full agenda.
|
|
|
|
Virtual: Life Sciences
Summit 2020
November 17-18, 2020
|
|
Don't miss the Center for Biotechnology's live virtual Life Sciences Summit 2020 on November 17th -18th. Join us we spotlight the next wave of emerging companies and academic innovators, connect ventures and technologies with the capital and strategic partners needed to move new discoveries into clinical development, and address issues impacting the next generation of company leaders.
|
|
 |
SBIR/STTR Virtual Workshop
October 21-22
Thinking of writing an SBIR/STTR proposal or just Interested in learning more about the program?
Led by experts from BBC Entrepreneurial Training & Consulting, join our live Virtual Classroom for an interactive, 1.5 daySBIR/STTR workshop. We'll review the basics including program purpose; eligibility; and sources of funding. Then we’ll provide proposal prep essentials of the NIH and NSF programs. This event is free to attend but registration is required. Register here. View
______________
If you have news or events that you'd like us to feature in our weekly newsletter,
email Mary Bartlett.
mary.bartlett@newyorkbio.org
|
|
|
|
Virtual: Show Up for Science Virtual Celebration
October 27
Join the New York Stem Cell Foundation for a lively introduction to stem cell research; a virtual tour of NYSCF’s pioneering work in COVID-19, Alzheimer’s, Parkinson’s, diabetes, multiple sclerosis, cancer, and macular degeneration; and a tribute to our three 2020 Stem Cell Heroes.
Show Up for Science
October 27, 2020
7:00 – 8:00 PM
Hosted by Sanjay Gupta, MD
Directed by Scott Ellis
Featuring Special Guests:
Jesse Tyler Ferguson
Whoopi Goldberg
Jane Krakowski
Billy Porter
and more to be announced!
|
|
|
|
On Monday, Charles M. Rice, the Maurice R. and Corinne P. Greenberg Professor in Virology and Head of the Laboratory of Virology and Infectious Disease at The Rockefeller University, was named recipient of the 2020 Nobel Prize in Medicine or Physiology. Dr. Rice will share this award with Harvey J. Alter of the National Institutes of Health and Michael Houghton of the University of Alberta, Canada. The award recognizes their discovery of the Hepatitis C virus, which causes chronic liver disease in 70 million people worldwide and causes 400,000 deaths annually.
Dr. Rice’s remarkable work is the embodiment of the Rockefeller credo, “Science for the benefit of humanity.” We congratulate him and are so pleased that he has received this exceptionally well-deserved recognition!
|
|
Partnering with BIO to engage biotech in the election |
|
|
|
As you know, the election is fast approaching and so is the deadline to register to vote. In New York, voters must register by TODAY October 9th to vote in the November 3rd election. We've partnered with BIO to give you all the information you need to engage. It's important to confirm that you are registered to vote! Use the link below to visit our website with BIO and to learn about your candidates and biotech's policy priorities.
|
|
|
|
|
|
|
